3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Motor Activity
30
Breast Neoplasms
19
Neoplasms
13
Prostatic Neoplasms
10
Obesity
6
Colorectal Neoplasms
6
Sarcopenia
5
Pancreatic Neoplasms
5
Lung Neoplasms
4
Signs and Symptoms
3
Polycystic Ovary Syndrome
3
Multiple Myeloma
3
Lymphedema
3
Inflammation
3
Head and Neck Neoplasms
3
Fatigue
3
Diabetes Mellitus, Type 2
3
Colonic Neoplasms
3
Brain Neoplasms
3
Uterine Cervical Neoplasms
2
Osteoporosis, Postmenopausal
2
Osteoporosis
2
Lymphoma
2
Leukemia
2
Diabetes Mellitus
2
Carcinoma, Non-Small-Cell Lung
2
Cachexia
2
Weight Loss
1
Uterine Neoplasms
1
Urinary Incontinence
1
Interventions
Cyclophosphamide
16
fludarabine phosphate
13
Peripheral Blood Stem Cell Transplantation
13
Whole-Body Irradiation
10
Cyclosporine
10
Antilymphocyte Serum
9
Melphalan
8
Busulfan
8
Mycophenolic Acid
7
Filgrastim
6
fludarabine
5
Radiotherapy
5
Methotrexate
5
Etoposide
5
Psychiatric Rehabilitation
4
Methylprednisolone
4
Cytarabine
4
Carmustine
4
Blood Specimen Collection
4
thymoglobulin
3
Therapeutics
3
Rituximab
3
Flow Cytometry
3
Aprepitant
3
Analgesia
3
Tacrolimus
2
Stem Cell Transplantation
2
Proton Therapy
2
Polymerase Chain Reaction
2
Ondansetron
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Hodgkin Disease
×
Resistance Training
×
Clear all
NCT05556239
2025-12-08
STAY-STRONG
Rigshospitalet, Denmark
Phase NA
Completed
42 enrolled